Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,142.19
(
0.06%
)
US TECH 100
26,245.40
(
0.16%
)
Dow Jones
49,425.56
(
-0.13%
)
Brent Oil
98.62
(
1.96%
)
Bitcoin
78,508.49
(
0.35%
)
News Focus
News Focus
Post# of 517514
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Steady_T

Send PM Follow Ignore
Followers 169
Posts 23047
Boards Moderated 1
Alias Born 12/09/2004

Steady_T

Member Level

Re: peeved post# 374286

Tuesday, 09/20/2022 2:12:57 PM

Tuesday, September 20, 2022 2:12:57 PM

Post# of 517514
It was a Parkinson's Dementia trial. The motor improvements were a secondary endpoint. It was a P2 trial with moderate n of 132.

Still, the published results so far were pretty good. Theoretically Anavex is waiting on guidance from the FDA on proceeding with a P3 and PD trial guidance.

If investing was easy, everyone would be rich by now.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News